NVO
Novo Nordisk A/SNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$167.84B
P/E Ratio
10.59
EPS
$3.55
Beta
0.27
52W High
$77.68
52W Low
$34.58
50-Day MA
$43.17
200-Day MA
$52.72
Dividend Yield
4.88%
Profit Margin
33.10%
Forward P/E
11.05
PEG Ratio
4.96
About Novo Nordisk A/S
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Fundamentals
| Revenue (TTM) | $309.06B |
| Gross Profit (TTM) | $254.69B |
| EBITDA | $153.29B |
| Operating Margin | 44.50% |
| Return on Equity | 60.70% |
| Return on Assets | 17.40% |
| Revenue/Share (TTM) | $69.56 |
| Book Value | $6.74 |
| Price-to-Book | 5.46 |
| Price-to-Sales (TTM) | 0.54 |
| EV/Revenue | 3.739 |
| EV/EBITDA | 7.37 |
| Quarterly Earnings Growth (YoY) | -4.70% |
| Quarterly Revenue Growth (YoY) | -7.60% |
| Shares Outstanding | $3.36B |
| Float | $3.19B |
| % Insiders | 0.01% |
| % Institutions | 9.51% |
Analyst Ratings
Consensus ($47.59 target)
1
Strong Buy4
Buy9
HoldData last updated: 4/9/2026